The stock of Adaptimmune Therapeutics Plc ADR (ADAP) is currently priced at $0.06. In the last session, the stock climbed significantly, topping out at $1.5 after opening at $0.06. The day’s lowest price was $0.09 before the stock closed at $0.06.
Adaptimmune Therapeutics Plc ADR’s market performance has been unstable in recent times. The company’s stock hit a 1-year high of $1.33 on 08/26/24 and a low of $0.05 for the same time frame on 08/20/25.
52-week price history of ADAP Stock
Studying a stock’s 52-week price history, which includes both low and high prices, can help gauge its current status and potential future performance. Adaptimmune Therapeutics Plc ADR’s current trading price is -95.72% away from its 52-week high, while its distance from the 52-week low is 9.42%. The stock’s price range during the 52-week period has remained between $0.05 and $1.33. In the Healthcare sector, the company’s shares saw a trading volume of around 25.69 million for the day, which was evidently lower than the average daily volume of 28.3 million over the past three months.
Market Capitalization and Financial Performance: An In-Depth Look
Adaptimmune Therapeutics Plc ADR (ADAP) has experienced a quarterly decline of -79.26% in its revenues when compared to the same period in the previous year. Presently, the company has a total market capitalization of 15.08M and boasts a workforce of 506 employees.
A Closer Look at Analysts’ Ratings for Adaptimmune Therapeutics Plc ADR
As of right now, 0 analyst is rating Adaptimmune Therapeutics Plc ADR as a BUY, 0 of the polled analysts branded the stock as an OVERWEIGHT, 4 analysts are recommending to HOLD this stock, 1 of them gave the stock UNDERWEIGHT rating, and 0 analyst is rating the stock as SELL.
Making Sense of Trading Volume and Moving Average Data
Based on Barchart.com data, the company’s moving average over the 100-day period was 0.2304, with a change in price of -0.1401. Similarly, Adaptimmune Therapeutics Plc ADR recorded 18,752,146 in trading volume during the last 100 days, posting a change of -71.12%.
ADAP Stock Stochastic Average
As of today, Adaptimmune Therapeutics Plc ADR’s raw stochastic average for the last 50 days stands at 1.60%. This is a decline compared to the raw stochastic average of the previous 20 days, which was noted at 4.92%. Furthermore, the company’s Stochastic %K and %D values for the past 20 days were 2.92% and 2.18%, respectively.
ADAP Stock Price Performance Analysis
The performance of the stock price over the year has been up and down, leaving investors with either an optimistic or pessimistic outlook, depending on how they interpret the data. The metric has seen a significant loss of -94.63% since the start of this calendar year. Looking back over the last six months, we can see a stronger performance of -89.83%. Over the past 30 days, the price of ADAP has leaped by -82.88%. And in the last five days, it has fallen by -4.37%.
